Statements

Court Examines Trump’s Statements on E. Jean Carroll: A Tale of Denials and Legal Precedents

by

New York, N.Y. — Legal tensions surrounding remarks made by former President Donald Trump about E. Jean Carroll have intensified as a court examines statements made over the past several years. Central to the case is whether these statements, made in 2019 and again in 2022, contain false claims regarding the allegations of sexual assault brought against him. In both instances, Trump suggested that Carroll fabricated her accusations for personal gain. The essence of both sets of statements challenges the truth of Carroll’s allegations, fundamentally questioning whether Trump assaulted her in 1996. The legal ramifications … Read more

Appeals Court Affirms $83.3 Million Defamation Award Against Trump, Highlighting Impact of His Statements on E. Jean Carroll

by

New York, New York — A federal appeals court has confirmed an $83.3 million jury award in favor of writer E. Jean Carroll in her defamation case against former President Donald Trump. The ruling dismissed Trump’s claims that the damages were excessive and that he was protected by presidential immunity regarding statements made about Carroll on social media and in public. The U.S. Court of Appeals for the Second Circuit determined that Trump made several public statements about Carroll that exposed her to threats and harassment. The court highlighted that Trump portrayed Carroll as driven … Read more

Pa. Appeals Court Orders New Medical Malpractice Trial Due to Inflammatory Opening Statements and Jury Instruction Flaws

by

PITTSBURGH — A Pennsylvania appeals court has ruled that a new medical malpractice trial is warranted due to improper opening statements and jury instructions during the original trial. The decision stems from a case involving a patient who alleged that inadequate care led to significant health complications. The three-judge panel’s ruling emphasized that the initial trial proceedings were impacted by prejudicial remarks made by the defendant’s attorney. These statements, deemed misleading, could have swayed the jury’s perception. Legal experts suggest that such comments can severely undermine the fairness of a trial, especially in complex medical … Read more

Capricor Therapeutics Faces Class Action Lawsuit as Investors Claim Misleading Statements Led to Financial Losses

by

Los Angeles, Calif. — A class action lawsuit has been initiated against Capricor Therapeutics, Inc. (CAPR) in response to claims that the company’s stock was sold at inflated prices. Filed by the law firm Levi & Korsinsky on July 17, 2025, the lawsuit alleges that shareholders purchased stock during a defined class period from October 9, 2024, to July 10, 2025, without full knowledge of the company’s actual financial condition. Affected investors are being encouraged to seek information on participation in the action. Capricor Therapeutics is engaged in the development of innovative cell and exosome-based … Read more